FAM25A Inhibitors
FAM25A inhibitors represent a distinct class of chemical compounds designed to selectively impede the biochemical functions of the FAM25A protein. FAM25A, a protein encoded by the FAM25A gene, potentially plays a role in certain cellular processes, although its specific biological functions are not thoroughly characterized within scientific literature. Inhibitors targeting this protein would, by design, interact with the active sites or allosteric sites of FAM25A, obstructing its interaction with other molecular partners or its involvement in signaling cascades. The inhibitors are crafted to ensure high specificity to avoid off-target effects that might disrupt related proteins with similar structural motifs or domains. The chemical composition of these inhibitors is such that they bind with high affinity, diminishing the functional activity of FAM25A by stabilizing it in an inactive conformation or by preventing post-translational modifications essential for its activity.
The design of FAM25A inhibitors is a sophisticated process that takes into account the three-dimensional structure of the protein, aiming to exploit unique conformational features that are critical for its function. These inhibitors might function by mimicking the substrate or product states of FAM25A-mediated reactions, thereby acting as competitive inhibitors, or they might integrate into the regulatory regions of the protein to cause non-competitive inhibition. The action of these inhibitors is expected to result in a decrease in the normal activity of the FAM25A protein within the cell, which may influence the cellular pathways or biological processes where FAM25A is a key contributor. By reducing the functional activity of FAM25A, these inhibitors would logically alter the downstream effects mediated by the protein. The overall goal in the development of FAM25A inhibitors is to achieve precise modulation of the protein's activity without inducing toxicity or unwanted effects on other proteins or cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). By inhibiting CDK4/6, it suppresses retinoblastoma (Rb) protein phosphorylation, halting the cell cycle at the G1 phase. If FAM25A is involved in cell cycle regulation, palbociclib would reduce its activity by preventing cell cycle progression where FAM25A may act. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that binds to FKBP12 and the resulting complex inhibits mTORC1 signaling. By inhibiting mTORC1, it can downregulate protein synthesis and cell growth, potentially decreasing the functional activity of FAM25A if its function is tied to these cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which prevents the phosphorylation of PIP2 to PIP3. This action inhibits AKT signaling, leading to reduced cell survival and proliferation. Inhibition of this pathway may indirectly decrease the activity of FAM25A if it is downstream or reliant on PI3K/AKT signaling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDAC). By inhibiting HDAC, it alters chromatin structure and affects gene expression. If FAM25A expression is regulated by HDAC-mediated chromatin remodeling, Trichostatin A could decrease its expression and activity. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is a neutral sphingomyelinase inhibitor, which leads to decreased levels of ceramide, a lipid that can induce apoptosis. If FAM25A activity is associated with apoptotic signaling, GW4869 might reduce its functional activity by diminishing ceramide-mediated apoptosis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which prevents the activation of the MAPK/ERK signaling pathway. By inhibiting this pathway, U0126 can affect cell cycle, differentiation, and survival. If FAM25A functions within the MAPK/ERK pathway, its activity would be indirectly inhibited. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of the JNK signaling pathway, which modulates processes like cell growth and apoptosis. If FAM25A is involved in JNK-related cellular responses, the use of SP600125 could lead to decreased activity of FAM25A. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor type I. It prevents phosphorylation of SMAD proteins, thereby inhibiting TGF-β signaling. If FAM25A is involved in this signaling pathway, SB431542 could indirectly reduce the activity of FAM25A. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (3-MA) inhibits autophagy by blocking autophagosome formation. This is achieved through the inhibition of class III PI3K. If FAM25A is associated with the autophagic process, 3-MA could decrease its functional activity. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a broad-spectrum caspase inhibitor that prevents apoptosis. If FAM25A's activity is linked to apoptotic pathways, inhibiting caspases could indirectly reduce the functional activity of FAM25A. | ||||||